Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART)

European Journal of Pediatrics

Volumn 166, Issue 1, 2007, Pages 51-56

  Ching, Natascha ^a   Deville, Jaime G ^a   Nielsen, Karin A ^a   Ank, Bonnie ^a   Wei, Lian S ^a   Sim, Myung Shin ^a   Wolinsky, Steven M ^b   Bryson, Yvonne J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

HAART; HIV 1; Immune reconstitution; Immunization; Tetanus toxoid

Indexed keywords

CD4 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFARIX; TETANUS ANTIBODY; TETANUS TOXOID;

ADOLESCENT; ANTIBODY PRODUCTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG RESPONSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MALE; OUTCOME ASSESSMENT; PERINATAL INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TETANUS; TETANUS PROPHYLAXIS; UNITED STATES; VIREMIA;

ANTIBODY FORMATION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; FEMALE; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; TETANUS TOXOID; VACCINATION;

EID: 33845417932     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0184-2     Document Type: Article

References (21)

1. Al-Attar I, Reisman J, Muehlmann M, McIntosh K (1995) Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 14(2):149-151
2. Autran B, Carcelain G, Debre P (2001) Immune reconstitution after highly active anti-retroviral treatment of HIV infection. Adv Exp Med Biol 495:205-212
3. Borkowsky W, Steele CJ, Grubman S, Moore T, La Russa P, Krasinski K (1987) Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus. J Pediatr 110(4):563-566
4. Borut TC, Ank BJ, Gard SE, Stiehm ER (1980) Tetanus toxoid skin test in children: correlation with in vitro lymphocyte stimulation and monocyte chemotaxis. J Pediatr 97(4):567-573
5. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G (1995) A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 332(12):761-766
6. Gibb D, Giacomelli A, Masters J, Spoulou V, Ruga E, Griffiths H, Kroll S, Giaquinto C, Goldblatt D (1996) Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. Pediatr Infect Dis J 15(12):1097-1101
7. Hainaut M, Ducarme M, Schandene L, Peltier CA, Marissens D, Zissis G, Mascart F, Levy J (2003) Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 22(1):62-69
8. Johnston AM, Valentine ME, Ottinger J, Baydo R, Gryszowka V, Vavro C, Weinhold K, St Clair M, McKinney RE (2001) Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study. Pediatr Infect Dis J 20(10):941-946
9. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B (1998) Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 351(9117):1682-1686
10. Lima M, De Menezes Succi RC, Nunes Dos Santos AM, Weckx LY, De Moraes-Pinto MI (2004) Rubella immunization in human immunodeficiency virus type 1-infected children: cause for concern in vaccination strategies. Pediatr Infect Dis J 23(7):604-607
11. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M (2002) Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 136(9):660-666
12. Melvin AJ, Mohan KM (2003) Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. Pediatrics 111(6 Pt 1):e641-e644
13. Resino S, Correa R, Bellon JM, Sanchez-Ramon S, Munoz-Fernandez MA (2002) Characterizing immune reconstitution after long-term highly active antiretroviral therapy in pediatric AIDS. AIDS Res Hum Retroviruses 18(18):1395-1406
14. Rosenblatt HM, Song LY, Nachman SA, Stanley KE, Krogstad PA, Johnson GM, Wiznia AA (2005) Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection. J Allergy Clin Immunol 116(3):698-703
15. Simonsen O, Bentzon MW, Heron I (1986) ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 14(3):231-239
16. Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, St Clair M, Kuritzkes DR, Kessler H, Fox L, Blanchard-Vargas M, Landay A (2002) Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 16(14):1859-1866
17. Valdez H, Smith KY, Landay A, Connick E, Kuritzkes DR, Kessler H, Fox L, Spritzler J, Roe J, Lederman MB, Lederman HM, Evans TG, Heath-Chiozzi M, Lederman MM (2000) Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. AIDS 14(1):11-21
18. van Rossum AM, Scherpbier HJ, van Lochem EG, Pakker NG, Slieker WA, Wolthers KC, Roos MT, Kuijpers JH, Hooijkaas H, Hartwig NG, Geelen SP, Wolfs TF, Lange JM, Miedema F, de Groot R (2001) Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS 15(17):2267-2275
19. Virella G, Hyman B (1991) Quantitation of anti-tetanus and antidiphtheria antibodies by enzymoimmunoassay: methodology and applications. J Clin Lab Anal 5(1):43-48
20. Wassilak SGF, Roper MH, Murphy TV, Orenstein WA (2004) Tetanus toxoid. In: Plotkin SA, Orenstein WA (eds) Vaccines. Saunders, Philadelphia, Pennsylvania, pp 745-781
21. Weinberg A, Pahwa S, Oyomopito R, Carey VJ, Zimmer B, Mofenson L, Kovacs A, Burchett SK (2004) Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 39(1):107-114